Andrea Luigi Cavalot
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andrea Luigi Cavalot has a total of 170 co-authors. Here are the top co-authors by number of shared publications:
- Roberto Albera
Division of Otorhinolaryngology, Department of Surgical Sciences, University of Turin, 10126 Turin, Italy
14 shared publications Giorgio Cortesina
Dipartimento di Fisiopatologia Clinica sezione ORL II Università degli Studi di Torino Turin Italy
10 shared publications- Antonio Schindler
Department of Biomedical and Clinical Sciences, University of Milan, 20157 Milan, Italy
8 shared publications Giuliana Preti
Department of Clinic Phisiophatology University of Turin Turin Italy
6 shared publicationsNicola Vione
6 shared publicationsFrancesca Palonta
5 shared publications
Latest Publications
- Open Access
- 1 December 2014
- Published by Elsevier in Immunology Letters
- Vol. 162 (2) , 185-193
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: The results of a double blind, placebo controlled, multicenter clinical trial
- 1 December 2014
- Published by Elsevier in Immunology Letters
- Vol. 162 (2) , 185-193
Open AccessThe bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: The results of a double blind, placebo controlled, multicenter clinical trial
- 1 March 2011
- Published by Elsevier in Clinical Oncology
- Vol. 23 (2) , 134-140
Concomitant Adjuvant Chemoradiotherapy with Weekly Low-dose Cisplatin for High-risk Squamous Cell Carcinoma of the Head and Neck: a Phase II Prospective Trial
- 1 March 2011
- Published by Elsevier in Clinical Oncology
- Vol. 23 (2) , 134-140
Concomitant Adjuvant Chemoradiotherapy with Weekly Low-dose Cisplatin for High-risk Squamous Cell Carcinoma of the Head and Neck: a Phase II Prospective Trial
- 1 June 2009
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 140 (6) , 822-825
The importance of preoperative swallowing therapy in subtotal laryngectomies
Objective: To examine the utility of swallowing therapy (ST) before and after surgery in patients undergoing subtotal laryngectomy.Study Design and Setting: From 1990 to 2000, 43 patients underwent subtotal laryngectomy. Prior to 1997 patients received ST only after surgery, while from 1997 on, patients scheduled for subtotal laryngectomy also received some sessions of ST before surgery.Results: The average time to swallowing resumption was 27.76 ± 5.206 days for the 25 patients who received ST only after surgery, and 16.38 ± 2.953 for those who underwent ST both before and after surgery.Conclusion: The difference between the two groups was significant on Student's t test (P < 0.001) and shows that preoperative rehabilitation is of significant help in the early resumption of normal deglutition.Significance: The authors find that the duration of nasogastric tube feeding is reduced in subjects who underwent ST.
- 1 June 2009
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 140 (6) , 822-825
The importance of preoperative swallowing therapy in subtotal laryngectomies
Objective: To examine the utility of swallowing therapy (ST) before and after surgery in patients undergoing subtotal laryngectomy.Study Design and Setting: From 1990 to 2000, 43 patients underwent subtotal laryngectomy. Prior to 1997 patients received ST only after surgery, while from 1997 on, patients scheduled for subtotal laryngectomy also received some sessions of ST before surgery.Results: The average time to swallowing resumption was 27.76 ± 5.206 days for the 25 patients who received ST only after surgery, and 16.38 ± 2.953 for those who underwent ST both before and after surgery.Conclusion: The difference between the two groups was significant on Student's t test (P < 0.001) and shows that preoperative rehabilitation is of significant help in the early resumption of normal deglutition.Significance: The authors find that the duration of nasogastric tube feeding is reduced in subjects who underwent ST.
- 20 May 2009
- Published by Wiley in The Laryngoscope
- Vol. 119 (6) , 1218-1225
Supracricoid laryngectomy: Age influence on long‐term functional results
Objectives/Hypothesis: Supracricoid laryngectomies (SCL) are conservative surgical techniques for the treatment of selected laryngeal carcinomas, currently adopted also in old patients. Long‐term functional results have not been reported in elderly patients. The aim of this study is to compare voice and swallowing in elderly and younger patients following SCL.Study Design: Cross‐sectional study.Methods: Twenty male patients who underwent SCL were recruited in the study; 10 were younger than 65 years at the time of surgery and 10 were older. Video‐endoscopic ratings were taken of neoglottic vibration patterns and bolus transit. Voices were perceptually rated using the GIRBAS scale. The maximum phonation time (MPT) and the syllables diadochokinesis were measured. Spectrograms were recorded. All of the patients completed a self‐assessment questionnaire for both voice and swallowing. The data obtained from the two groups were compared through the Mann‐Whitney test.Results: Video‐endoscopic ratings of neoglottal vibration and bolus transit showed no difference between the two groups. The perceptual assessment showed a harsh voice in both groups. No significant difference was found for mean syllable diadochokinesis and the mean MPT was 6.3 seconds and 8.8 seconds, respectively in the younger and older group. The mean value of the Yanagihara scale of voice spectrogram was 3.8 and 3.7. Voice and swallowing quality‐of‐life questionnaires revealed satisfied patients in both age groups.Conclusions: Age by itself does not have a significant impact on long‐term functional results following SCL. Meticulous selection of the candidate to SCL allows the application of this surgical technique with adequate long‐term functional results. Laryngoscope, 2009
- 20 May 2009
- Published by Wiley in The Laryngoscope
- Vol. 119 (6) , 1218-1225
Supracricoid laryngectomy: Age influence on long‐term functional results
Objectives/Hypothesis: Supracricoid laryngectomies (SCL) are conservative surgical techniques for the treatment of selected laryngeal carcinomas, currently adopted also in old patients. Long‐term functional results have not been reported in elderly patients. The aim of this study is to compare voice and swallowing in elderly and younger patients following SCL.Study Design: Cross‐sectional study.Methods: Twenty male patients who underwent SCL were recruited in the study; 10 were younger than 65 years at the time of surgery and 10 were older. Video‐endoscopic ratings were taken of neoglottic vibration patterns and bolus transit. Voices were perceptually rated using the GIRBAS scale. The maximum phonation time (MPT) and the syllables diadochokinesis were measured. Spectrograms were recorded. All of the patients completed a self‐assessment questionnaire for both voice and swallowing. The data obtained from the two groups were compared through the Mann‐Whitney test.Results: Video‐endoscopic ratings of neoglottal vibration and bolus transit showed no difference between the two groups. The perceptual assessment showed a harsh voice in both groups. No significant difference was found for mean syllable diadochokinesis and the mean MPT was 6.3 seconds and 8.8 seconds, respectively in the younger and older group. The mean value of the Yanagihara scale of voice spectrogram was 3.8 and 3.7. Voice and swallowing quality‐of‐life questionnaires revealed satisfied patients in both age groups.Conclusions: Age by itself does not have a significant impact on long‐term functional results following SCL. Meticulous selection of the candidate to SCL allows the application of this surgical technique with adequate long‐term functional results. Laryngoscope, 2009
- 2 February 2009
- Published by Wiley in Head & Neck
- Vol. 31 (8) , 1102-1106
Playing a brass instrument after total laryngectomy: A case report
Background A brass instrument is a musical instrument in which the tone is produced by vibration of the lips as the player blows into a tubular resonator. The case of a professional brass player who continued his activity after total laryngectomy, with insertion of a voice prosthesis in a tracheoesophageal shunt, is reported. Methods A videoendoscopic and videofluoroscopic study of the patient during brass playing was conducted. Results A nonvibrating, open neoglottis during brass playing was found on videoendoscopy. Videofluorography revealed an enlarged hypopharynx, a thick neoglottis while playing at lower tone; at higher pitch the tongue base was retracted, the neoglottis was thin and stretched, and the subneoglottic area was extremely enlarged. Conclusion The case reported shows that the insertion of a voice prosthesis in a tracheoesophageal shunt seems to create a regulating airflow system sufficiently advanced to play a brass instrument, further reducing the disability of laryngeal speakers. © 2009 Wiley Periodicals, Inc. Head Neck, 2009
- 2 February 2009
- Published by Wiley in Head & Neck
- Vol. 31 (8) , 1102-1106
Playing a brass instrument after total laryngectomy: A case report
Background A brass instrument is a musical instrument in which the tone is produced by vibration of the lips as the player blows into a tubular resonator. The case of a professional brass player who continued his activity after total laryngectomy, with insertion of a voice prosthesis in a tracheoesophageal shunt, is reported. Methods A videoendoscopic and videofluoroscopic study of the patient during brass playing was conducted. Results A nonvibrating, open neoglottis during brass playing was found on videoendoscopy. Videofluorography revealed an enlarged hypopharynx, a thick neoglottis while playing at lower tone; at higher pitch the tongue base was retracted, the neoglottis was thin and stretched, and the subneoglottic area was extremely enlarged. Conclusion The case reported shows that the insertion of a voice prosthesis in a tracheoesophageal shunt seems to create a regulating airflow system sufficiently advanced to play a brass instrument, further reducing the disability of laryngeal speakers. © 2009 Wiley Periodicals, Inc. Head Neck, 2009
- 29 May 2008
- Vol. 28, 1285-91
Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma.
A phase II study was carried out to investigate an induction regimen with cisplatin, paclitaxel followed by radiotherapy concurrent with weekly cisplatin for locally advanced squamous cell carcinoma of the head and neck. Stage III-IV disease patients were eligible. Two cisplatin (100 mg/m2) and paclitaxel (175 mg/m2) courses were administered every 21 days followed by standard fractionated external beam radiotherapy (approximately 70 Gy), concomitant to weekly cisplatin (30 mg/m2). Thirty-five patients were enrolled: over 70% had unresectable disease with bulky lesions. Grade 3-4 neutropenia developed in 14% and G3 mucositis in 23%. Locoregional control was achieved in 51%. Median time to progression and overall survival were 10,7 and 17 months respectively; 2- and 3-year survival rates were 30% and 25% respectively. Our induction two-drug regimen followed by chemoradiotherapy with concurrent weekly cisplatin was well tolerated with low acute toxicity and good locoregional control and survival rate.
- 29 May 2008
- Vol. 28, 1285-91
Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma.
A phase II study was carried out to investigate an induction regimen with cisplatin, paclitaxel followed by radiotherapy concurrent with weekly cisplatin for locally advanced squamous cell carcinoma of the head and neck. Stage III-IV disease patients were eligible. Two cisplatin (100 mg/m2) and paclitaxel (175 mg/m2) courses were administered every 21 days followed by standard fractionated external beam radiotherapy (approximately 70 Gy), concomitant to weekly cisplatin (30 mg/m2). Thirty-five patients were enrolled: over 70% had unresectable disease with bulky lesions. Grade 3-4 neutropenia developed in 14% and G3 mucositis in 23%. Locoregional control was achieved in 51%. Median time to progression and overall survival were 10,7 and 17 months respectively; 2- and 3-year survival rates were 30% and 25% respectively. Our induction two-drug regimen followed by chemoradiotherapy with concurrent weekly cisplatin was well tolerated with low acute toxicity and good locoregional control and survival rate.
- Open Access
- 1 September 2007
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (17) , 5089-5094
Association Between Hypermethylated Tumor and Paired Surgical Margins in Head and Neck Squamous Cell Carcinomas
Purpose: Surgical margin status is reported to be a relevant prognostic factor in head and neck squamous cell carcinoma (HNSCC), associated with a high risk of local recurrence. This study examines whether gene-promoter hypermethylation could be detected in HNSCC surgical margins with no histologic evidence of malignancy, and if so, whether it reflects epigenetic events of primary tumors.
- 1 September 2007
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (17) , 5089-5094
Open AccessAssociation Between Hypermethylated Tumor and Paired Surgical Margins in Head and Neck Squamous Cell Carcinomas
Purpose: Surgical margin status is reported to be a relevant prognostic factor in head and neck squamous cell carcinoma (HNSCC), associated with a high risk of local recurrence. This study examines whether gene-promoter hypermethylation could be detected in HNSCC surgical margins with no histologic evidence of malignancy, and if so, whether it reflects epigenetic events of primary tumors.
- 21 February 2007
- Published by Wiley in Head & Neck
- Vol. 29 (7) , 655-664
Prognostic impact of HER‐2/neu expression on squamous head and neck carcinomas
Background.: HER‐2/neu gene amplification and protein overexpression have been identified in various solid tumors, but its prognostic relevance in head and neck squamous cell carcinoma (HNSCC) is still controversial.Methods.: The study investigated the expression of HER‐2/neu oncoprotein in HNSCC and sought possible correlations to various clinicopathologic parameters. Expression of HER‐2/neu oncoprotein was assessed in archival tumor tissues from 87 untreated HNSCC patients by immunohistochemical technique. Data were correlated with both the clinicopathologic parameters and patient survival.Results.: A high membranous HER‐2/neu protein expression level was found in 39% of patients. Multivariate analysis indicated that HER‐2/neu protein expression and pN lymph‐node status were independent prognostic factors for disease‐free survival.Conclusions.: HER2/neu overexpression and its relationship with survival suggest that new therapeutic approaches targeting epidermal growth factor receptor (EGFR) family receptors could provide a new way of treating HNSCC patients with HER2/neu‐positive neoplastic lesions. © 2007 Wiley Periodicals, Inc. Head Neck, 2007
- 21 February 2007
- Published by Wiley in Head & Neck
- Vol. 29 (7) , 655-664
Prognostic impact of HER‐2/neu expression on squamous head and neck carcinomas
Background.: HER‐2/neu gene amplification and protein overexpression have been identified in various solid tumors, but its prognostic relevance in head and neck squamous cell carcinoma (HNSCC) is still controversial.Methods.: The study investigated the expression of HER‐2/neu oncoprotein in HNSCC and sought possible correlations to various clinicopathologic parameters. Expression of HER‐2/neu oncoprotein was assessed in archival tumor tissues from 87 untreated HNSCC patients by immunohistochemical technique. Data were correlated with both the clinicopathologic parameters and patient survival.Results.: A high membranous HER‐2/neu protein expression level was found in 39% of patients. Multivariate analysis indicated that HER‐2/neu protein expression and pN lymph‐node status were independent prognostic factors for disease‐free survival.Conclusions.: HER2/neu overexpression and its relationship with survival suggest that new therapeutic approaches targeting epidermal growth factor receptor (EGFR) family receptors could provide a new way of treating HNSCC patients with HER2/neu‐positive neoplastic lesions. © 2007 Wiley Periodicals, Inc. Head Neck, 2007
- 1 November 2006
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 27 (6) , 378-383
Long-term voice and swallowing modifications after supracricoid laryngectomy: objective, subjective, and self-assessment data
- 1 November 2006
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 27 (6) , 378-383
Long-term voice and swallowing modifications after supracricoid laryngectomy: objective, subjective, and self-assessment data
- 1 September 2006
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 135 (3) , 476-477
A surgical technique for macrostoma reduction after laryngectomy
- 1 September 2006
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 135 (3) , 476-477
A surgical technique for macrostoma reduction after laryngectomy